Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Åsa Jellvert"'
Autor:
Magnus Lindskog, Anna Laurell, Anders Kjellman, Bohuslav Melichar, Pablo Maroto Rey, Henryk Zieliński, Felipe Villacampa, Pierre Bigot, Bajory Zoltan, Omi Parikh, David Vazquez Alba, Åsa Jellvert, Tibor Flaskó, Enrique Gallardo, Maria José Ribal Caparrós, Gunta Purkalne, Peter Suenaert, Alex Karlsson-Parra, Börje Ljungberg
Publikováno v:
European Urology Open Science, Vol 40, Iss , Pp 38-45 (2022)
Background: The prognosis of patients with synchronous metastatic renal cell carcinoma (mRCC) is poor. Whereas single-agent tyrosine kinase inhibition (TKI) is clearly insufficient, the effects can be enhanced by combinations with immune checkpoint i
Externí odkaz:
https://doaj.org/article/22606199b57147bda45ec3fa0f159cf7
Autor:
Daniel Åhs, Josefin Olausson, Jan-Erik Damber, Ingela Franck Lissbrant, Karin Welén, Åsa Jellvert
Publikováno v:
Acta oncologica (Stockholm, Sweden). 57(7)
Low-dose metronomic chemotherapy (LDMC) is an alternative for treatment of patients with late-stage prostate cancer (PC) not susceptible to regular chemotherapy due to its severe side effects. The exact working mechanisms of LDMC have not been establ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ff33cf6c876051e818e2b6d329f178
https://pubmed.ncbi.nlm.nih.gov/29299975
https://pubmed.ncbi.nlm.nih.gov/29299975